Eli Lilly and Co (LLY)
734.97
-20.94
(-2.77%)
USD |
NYSE |
May 03, 16:00
738.49
+3.52
(+0.48%)
After-Hours: 20:00
Eli Lilly Total Assets (Quarterly): 63.94B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 63.94B |
December 31, 2023 | 64.01B |
September 30, 2023 | 57.92B |
June 30, 2023 | 54.81B |
March 31, 2023 | 53.16B |
December 31, 2022 | 49.49B |
September 30, 2022 | 47.46B |
June 30, 2022 | 47.06B |
March 31, 2022 | 46.92B |
December 31, 2021 | 48.81B |
September 30, 2021 | 48.19B |
June 30, 2021 | 47.81B |
March 31, 2021 | 46.84B |
December 31, 2020 | 46.63B |
September 30, 2020 | 43.95B |
June 30, 2020 | 41.97B |
March 31, 2020 | 41.10B |
December 31, 2019 | 39.29B |
September 30, 2019 | 37.89B |
June 30, 2019 | 38.67B |
March 31, 2019 | 38.01B |
December 31, 2018 | 43.91B |
September 30, 2018 | 44.63B |
June 30, 2018 | 42.36B |
March 31, 2018 | 44.36B |
Date | Value |
---|---|
December 31, 2017 | 44.98B |
September 30, 2017 | 43.01B |
June 30, 2017 | 40.95B |
March 31, 2017 | 37.62B |
December 31, 2016 | 38.81B |
September 30, 2016 | 37.59B |
June 30, 2016 | 36.48B |
March 31, 2016 | 34.69B |
December 31, 2015 | 35.57B |
September 30, 2015 | 36.30B |
June 30, 2015 | 36.04B |
March 31, 2015 | 35.65B |
December 31, 2014 | 36.31B |
September 30, 2014 | 34.65B |
June 30, 2014 | 35.02B |
March 31, 2014 | 34.76B |
December 31, 2013 | 35.25B |
September 30, 2013 | 33.97B |
June 30, 2013 | 33.23B |
March 31, 2013 | 32.30B |
December 31, 2012 | 34.40B |
September 30, 2012 | 34.32B |
June 30, 2012 | 31.81B |
March 31, 2012 | 32.24B |
December 31, 2011 | 33.66B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
37.89B
Minimum
Sep 2019
64.01B
Maximum
Dec 2023
48.30B
Average
47.26B
Median
Total Assets (Quarterly) Benchmarks
Amgen Inc | 92.98B |
Biogen Inc | 26.57B |
Madrigal Pharmaceuticals Inc | 640.55M |
Vertex Pharmaceuticals Inc | 22.73B |
Viking Therapeutics Inc | 967.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 51.05B |
Shareholders Equity (Quarterly) | 12.81B |
Debt to Equity Ratio | 2.046 |
Current Ratio | 1.354 |
Net Debt Paydown Yield | -0.27% |